|
Market Closed -
Nasdaq Stockholm
17:00:00 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 19.92 SEK | +2.47% |
|
+0.40% | -11.86% |
| 08-28 | Synact Pharma to present new preclinical data for resomelagon at WCI | FW |
| 08-20 | SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Nasdaq Stockholm
SYNACT 19.92 kr
+2.47%
3.36M
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| SYNACT | 19.92SEK | +2.47% | 3.36M kr | ||
CBOE
| 19.86SEK | +2.00% | 108K kr | ||
|
Deutsche Boerse AG
| 8F8 | 1.764EUR | +0.46% | 0 € | |
|
Börse Stuttgart
| 8F8 | 1.780EUR | +2.89% | 0 € | |
|
CBOE
| 21.45SEK | 0.00% | 0 kr | ||
|
Tradegate
| 8F8 | 1.788EUR | +1.71% | 0 € | |
|
Boerse Muenchen
| 8F8 | 1.782EUR | +1.37% | 0 € |
Quotes 5-day view: SynAct Pharma AB
Delayed Quote Nasdaq Stockholm
| 24/08/2026 | 25/08/2026 | 26/08/2026 | 27/08/2026 | 28/08/2026 | |
|---|---|---|---|---|---|
| Last | SEK 19.00 | SEK 19.66 | SEK 19.02 | SEK 19.44 | SEK 19.92 |
| Volume | 79,321 | 91,565 | 76,380 | 98,705 | 168,843 |
| Change | -4.23% | +3.47% | -3.26% | +2.21% | +2.47% |
| Opening | SEK 19.94 | SEK 19.18 | SEK 19.46 | SEK 19.20 | SEK 19.42 |
| High | SEK 20.00 | SEK 19.94 | SEK 19.88 | SEK 19.76 | SEK 20.00 |
| Low | SEK 18.74 | SEK 19.10 | SEK 18.98 | SEK 19.20 | SEK 19.12 |
Performance
| 1 day | +2.47% | ||
| 1 week | +0.40% | ||
| Current month | +9.09% | ||
| 1 month | +14.48% | ||
| 3 months | +14.35% | ||
| 6 months | +1.12% | ||
| Current year | -11.86% | ||
| 1 year | +11.91% | ||
| 3 years | -79.40% | ||
| 5 years | -82.15% | ||
| 10 years | +204.12% |
Volumes
marketsDaily volume
168,843
Estimated daily volume
168,843
Avg. Volume 20 sessions
143,835
Daily volume ratio
1.17
Avg. Volume 20 sessions SEK
2,865,193.2
Avg. Volume 20 sessions USD
298,716.45
Record volume 1
8,543,127
Record volume 2
8,361,601
Record volume 3
6,485,499
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (SEK)
1,115,485,543
Market Cap (USD)
116,373,031
Net sales (SEK)
0
Net sales (USD)
0
Number of employees
8
Sales / Employee (SEK)
0
Sales / Employee (USD)
0
Free-Float
66.53 %
Free-Float capitalization (SEK)
744,972,625
Free-Float capitalization (USD)
77,719,270
Average Daily Capital Traded
0.26%
Indicators
Moving average 5 days
19.41
Moving average 20 days
19.36
Moving average 50 days
18.74
Moving average 100 days
17.14
Price spread / (MMA5)
-2.57%
Price spread / (MMA20)
-2.84%
Price spread / (MMA50)
-5.92%
Price spread / (MMA100)
-13.95%
RSI 9 days
50.35
RSI 14 days
51.63
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.47% | +0.40% | +11.91% | -79.40% | 116M | |
| -0.13% | -6.44% | +60.34% | +112.06% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.13% | 646B | |
| -1.03% | -3.58% | +21.43% | +73.10% | 451B | |
| -1.46% | -4.50% | +37.80% | +37.41% | 355B | |
| -0.72% | -2.89% | +22.32% | +36.62% | 291B | |
| -1.19% | -2.21% | +1.53% | +10.79% | 252B | |
| -1.05% | -1.57% | +50.30% | +66.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.36% | 203B | |
| -2.14% | -0.30% | +28.95% | +86.27% | 181B | |
| Average | -0.43% | -2.37% | +26.82% | +35.22% | 365.94B | |
| Weighted average by Cap. | -0.46% | -3.46% | +38.17% | +65.00% |
Historical Quotes: SynAct Pharma AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
739e2b5e861.Cr1poD0CYW8JY-abkpiP8SV0IKx5q6WtO2Xd8eohjpM.Q9wq7ghUEgxYFp_X4vDnk24ADc0f0pXZY1WJvdxzw8Jf2QzBf0MjPUoFhQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:29:44 | 19.92 | 25 | 168,236 |
| 16:29:44 | 19.92 | 20 | 168,211 |
| 16:29:44 | 19.92 | 50 | 168,191 |
| 16:29:44 | 19.92 | 30 | 168,141 |
| 16:29:44 | 19.92 | 14 | 168,111 |
| 16:29:44 | 19.92 | 4 | 168,097 |
| 16:29:44 | 19.92 | 1 | 168,093 |
| 16:29:44 | 19.92 | 50 | 168,092 |
Price Extremes
| 1 week | 18.74 |  | 20 |
| 1 month | 17.7 | | 22.2 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
Monthly variations
Annual variations
| 2026 | -11.86% | ||
| 2025 | +152.09% | ||
| 2024 | +1.53% | ||
| 2023 | -89.17% | ||
| 2022 | -42.77% | ||
| 2021 | +221.44% | ||
| 2020 | +446.91% | ||
| 2019 | +21.99% | ||
| 2018 | -37.36% | ||
| 2017 | +82.76% | ||
| 2016 | +11.54% |
- Stock Market
- Stocks
- SYNACT Stock
- Quotes SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
